Pam Garside
Adjunct Professor @ Imperial College Business School
London, United Kingdom
Pam Garside is a seed investor at Imperial College Business School in London focused on Health Care and LGBT. Leading online Healthcare appointment booking service Zesty has strengthened its senior management team by appointing Pam Garside as its latest Board Advisor.Pam joins Zesty with over 35 years’ experience in the Healthcare sector. She has her own management consultancy, NewHealth, specialising in organisational strategy and development inhealth care, and is a Fellow of the Judge Business School of the University of Cambridge.She works extensively with boards of a wide range of health care organisations on leadership, governance and strategy issues. She began her professional life in management in the NHS and subsequently spent many years studying and working internationally based in the USA.Pam now spends her time working with Departments of Health, with NHS organisations, regulators, and the private sector in health in the UK. She also works with clients in the US and Australia and regularly convenes international health policy meetings. Pam Co-chairs The Cambridge Health Network, a membership group of senior players in UK health, both private and public sector.Pam is Senior Associate of the Nuffield Trust, an Adjunct Professor at Imperial College Business School, a member of the Advisory Board of Doctors.net.uk, a board member of the International Women’s Forum Leadership Foundation in Washington DC, C3, a non profit organisation working to address risk factors in chronic disease, and Diagnosis, a social enterprise promoting clinical leadership.Pam holds a BSc from the University of Durham and a Masters Degree in Hospital and Health Care Administration from the University of Minnesota.
- Total investments:
- 6
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Pam Garside invests in
Stages Pam Garside invests in
Countries Pam Garside invests in
Round sizes
Round size
- Seed
- $1.5M–$5.5M
Investment Focus
Industry
- Health Care 5 (83%)
- LGBT 1 (17%)
- Big Data 1 (17%)
- Internet 1 (17%)
- Software 1 (17%)
Stage
- Seed 4 (67%)
- Pre-Seed 1 (17%)
Country
- United Kingdom 4 (67%)
- United States 1 (17%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Paloma Health
|
A technology-enabled provider of children's mental health services, starting with autism assessments. | $2.6M / Pre-Seed / Nov 11, 2024 | |
Sanome
|
Sanome are combining different types of biomarkers to develop engaging, useful and accurate diagnostic products (IVDs) that enable early detection and prevention of disease. The IVD innovation engine, will ultimately enable new approaches for healthcare delivery, providing access to novel at-home testing paradigms for all people. | Seed / Jan 01, 2024 | |
Vinehealth
|
Vinehealth’s technology applies behavioural science and AI to deliver highly personalised patient support at scale; thereby generating rich patient-reported data to inform health service delivery, drug development and research. | $5.5M / Seed / Dec 03, 2021 | |
LVNDR Health
|
LVNDR is a digital platform that improves sexual wellbeing for LGBTQ+ individuals and modernises sexual healthcare for clinics. We facilitate access to remote care and empower users to take control of their health with greater access to tailored services and features designed to fit their needs. | $2.1M / Seed / Sep 23, 2021 | |
|
Vinehealth
|
Vinehealth’s technology applies behavioural science and AI to deliver highly personalised patient support at scale; thereby generating rich patient-reported data to inform health service delivery, drug development and research. | $1.5M / Seed / Jul 18, 2019 | |
Wellframe
|
Wellframe strategically partners with health plans nationwide to reimagine the relationship between plans and members. Our digital health management solutions for care management and advocacy enable a level of care and support that empowers people and organizations to achieve their best. By combining innovative solutions, strategic partnership, andpassionate conviction, Wellframe creates measurable impact on lives, at scale. | $1.5M / Seed / Apr 07, 2014 |
Co-Investors
About Imperial College Business School
Imperial College Business School inspires the best minds to become future business leaders.As part of Imperial College London, a global leader in science and technology, they drive business advantage through the fusion of business and technology.They combine innovative thinking and insight with new technology to develop practicalsolutions to real world issues, benefiting both business and society.Their world-leading research informs their postgraduate and Executive Education programmes and is sought by governments, policy-makers and global business leaders who often partner with us on research projects.They attract brilliant minds and provide the environment to foster innovative and entrepreneurial thinking, resulting in ground-breaking ideas that unlock business opportunities.Their life-long professional development service and global alumni network ensure their graduates go on to have long and successful careers in various industries all over the world.
Imperial College Business School Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Pam Garside
Adjunct Professor
|
|||
Alfonso Ferrandez
Module Leader
|
|||
Andrei Kirilenko
Visiting Professor
|
|||
Christopher Hunt
Professor & Lecturer
|
|||
David Shrier
Professor of Practice, AI & Innovation
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Pam Garside invest in?
Pam Garside invests primarily in Health Care, LGBT and Big Data startups, most often at Seed and Pre-Seed stage. Most of the 6 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Pam Garside's check size?
Pam Garside typically joins rounds of $1.5M–$5.5M at Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Pam Garside participates in.
When did Pam Garside last invest?
The most recent investment recorded for Pam Garside closed in Nov 2024. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
